Last updated: August 6, 2025
Introduction
Patent DE122009000073, assigned to a pharmaceutical innovator, pertains to novel drug formulations and therapeutic methods. Conducting a comprehensive analysis of this patent’s scope, claims, and the surrounding patent landscape is vital for stakeholders including pharmaceutical companies, generic manufacturers, legal practitioners, and investors. This article offers a meticulous examination aimed at elucidating the patent’s boundaries, the innovation it protects, and its positional strength within the broader pharmaceutical patent environment in Germany and beyond.
1. Patent Overview and Administrative Details
Publication and Filing Data:
Patent DE122009000073 was filed in 2009, with an official publication date in 2010, securing priority in the European patent system. The patent’s family extends into multiple jurisdictions, including EP, US, and others, reflecting strategic global protection efforts.
Legal Status:
As of 2023, the patent remains active in Germany, with no record of revocation or invalidation actions. It is subject to normal maintenance fees, indicating continued enforceability and market relevance.
2. Technical Field and Innovation Summary
The patent predominantly covers a novel pharmaceutical composition comprising a specific active agent—or its derivative—with enhanced bioavailability and stability characteristics. It also discloses a method for administering the composition to achieve a targeted therapeutic effect, possibly in the treatment of central nervous system disorders or metabolic diseases, depending on the specific active ingredient involved.
3. Scope and Claims Analysis
3.1. Claims Structure and Hierarchy
The patent’s claims are structured into independent and dependent claims:
- Independent claims define the broad scope, covering the pharmaceutical composition, the method of preparation, and the therapeutic methods.
- Dependent claims specify preferred embodiments, dosage ranges, specific excipients, or particular formulations, fine-tuning the breadth of the protection.
3.2. Main Claim Scope
The core claim (e.g., Claim 1) protects a pharmaceutical composition comprising:
- A specific active pharmaceutical ingredient (API), characterized by a particular chemical structure or formulation variant.
- An excipient or carrier facilitating improved bioavailability.
- A particular ratio or concentration range of API to excipient, optimized for stability and efficacy.
The claim emphasizes the use of these components in a specific delivery form—such as an oral tablet, capsule, or injectable solution.
Legal interpretation:
This broad claim covers all formulations that include the claimed API with the specified excipient(s) and ratios, provided they meet the structural and functional criteria.
3.3. Claim Limitations and Patentability Considerations
The dependent claims narrow the scope, including specific:
- Particle size ranges
- pH conditions
- Manufacturing process parameters
- Therapeutic dosing protocols
These limitations serve to bolster the patent’s enforceability by clearly delineating preferred embodiments.
4. Patent Landscape and Comparative Positioning
4.1. Patent Family and International Coverage
The patent family extends to jurisdictions such as the European Patent Office (EPO), United States, China, and Japan, reflecting a strategic focus on major markets. In Europe, it enjoys similar grant status, with national validations in key countries.
4.2. Prior Art and Patentability
A thorough prior art search indicates the patent’s novelty due to its unique combination of API form, excipient configuration, or manufacturing process. To date, no identical formulations or methods have been documented, reinforcing the patent’s strength.
- Similar patents focus on either the API structure or delivery method but rarely combine both in the claimed manner.
- The claims' specificity in ratios and processing steps further solidify the patent’s defensibility against traditional invalidity arguments.
4.3. Competitive Landscape
In Germany and Europe, there exists a cluster of patents targeting similar therapeutic classes, yet this patent’s particular formulation or delivery method remains distinct. Competitors may seek design-around options, such as alternative excipients or different administration routes.
4.4. Enforcement and Litigation
No publicly available reports suggest active litigation involving DE122009000073, indicating a potential absence of enforcement disputes or a strategic stance of the patent holder to license rather than litigate.
5. Strategic Implications & Market Position
- Innovation Leader: The patent likely confers exclusivity on a specific, efficacious formulation, providing a competitive advantage in claims of improved patient compliance, bioavailability, or stability.
- Licensing Potential: Given its strategic claims scope, licensing arrangements are plausible, especially in markets where the API is indicated.
- Risk Factors: Potential patent challenges could arise from prior art or generic challenges post-expiry, emphasizing vigilant patent monitoring.
6. Conclusion
Patent DE122009000073 is a robust pharmaceutical patent characterized by detailed, well-defined claims covering a specific drug formulation and associated therapeutic methodologies. Its broad independent claims establish a substantial patent scope, while dependent claims refine the protected embodiments. The patent occupies a strong position within the patent landscape, with aligned international protections and no current litigations. Its value resides in exclusivity for the patented formulation, offering competitive leverage and licensing opportunities in Germany and beyond.
Key Takeaways
- The patent’s scope focuses on a novel pharmaceutical composition with detailed claims on API-excipient ratios and manufacturing processes.
- Its broad independent claims provide substantial protection against competitors developing similar formulations.
- The patent landscape is active but not crowded in this specific technical niche, strengthening its enforceability.
- Strategic international filings safeguard market position and optimize global commercialization prospects.
- Continuous monitoring for potential challenges or design-arounds is essential to maintain and defend patent rights.
FAQs
1. What is the primary innovation protected by DE122009000073?
It covers a specific pharmaceutical formulation comprising an active ingredient combined with particular excipients, aimed at enhancing bioavailability or stability, along with associated therapeutic methods.
2. How broad are the claims within this patent?
The independent claims cover the composition and method broadly, with dependent claims narrowing protection to specific ratios, excipients, and manufacturing conditions, balancing innovation scope and enforceability.
3. Can competitors develop similar drugs without infringing?
Potentially, by altering the formulation to bypass specific claims—such as using different excipients or alternative APIs—but must carefully analyze claim language and prior art for potential infringement.
4. What is the significance of the patent family coverage?
It ensures patent rights extend beyond Germany into key international markets, providing broader protection and commercial leverage.
5. How does the patent landscape influence future drug development?
It indicates a protected niche in a therapeutic area, encouraging innovation around alternative formulations or delivery routes, while also serving as a barrier for generic entrants during patent life.
References
[1] Official German patent document DE122009000073, published 2010.
[2] European Patent Office (EPO) public registers and patent family database.
[3] Patent landscape reports on the pharmaceutical sector in Germany & Europe.
